Accurately Analyze Metal-Sensitive Compounds with Restek’s New Inert LC Columns
Restek’s new inert LC column technology helps labs improve their analysis of metal-sensitive compounds. A premium inert coating applied to the stainless-steel surface of Restek’s LC columns reduces nonspecific binding of chelating analytes, enabling sensitive analysis and smooth integration of peaks. Combined with Restek’s selective stationary phases, these new inert LC columns are ideal for the analysis of metal-sensitive compounds, such as mycotoxins and organophosphorus pesticides.
Restek's inert LC columns can provide four key benefits:
- Improved peak shape without passivation or mobile phase additives.
- Increased response and analyte recovery, allowing lower detection limits.
- High accuracy and throughput with less variability.
- Less time-consuming conditioning and complicated passivation required.
Restek’s inert LC column technology is available on three column types: Raptor Biphenyl, Raptor ARC-18, and Force Biphenyl. These new columns help bring the benefits of inert technology to labs specializing in small molecule LC-MS/MS workflows.
Learn more at: www.restek.com
Restek Corporation
1-814-353-1300, ext. 3
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.
